Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis

This study is for patients with Primary Sclerosing Cholangitis which is a chronic disease which causes scarring of the bile ducts. This can lead to damage of the liver over time. The purpose of this study is to see if an experimental medication slows the scarring process.
Laurie Peiffer at lpeiffer@pennstatehealth.psu.edu or 717-531-5226
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT03890120
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
18-70 years old
Diagnosis of Primary Sclerosing Cholangitisi
Exclusion Criteria:
Liver cirrhosis
Received a liver transplant
Liver cancer
HIV or Hepatitis B or C diagnosis
Alcohol use exceeding limits
Digestive Systems & Liver Disease
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA